Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

MOXIFLOXACIN HYDROCHLO

Active
SPE2DP-26-T-4348Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Moxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4348 with a required delivery of 10 bottles within 20 days FOB destination. Each bottle contains 30 tablets, with the unit of issue defined as a bottle, and the total quantity ordered is 10 bottles. The product must comply with strict packaging and labeling requirements as outlined in Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must be shipped using traceable means, excluding parcel post. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature while avoiding high humidity. Manufacturer information is specified, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. listed as suppliers, each with designated NDC numbers. All packaging must meet commercial standards per ASTM D3951 unless the material is hazardous, in which case Federal Standard 313 applies, though DLA Master List of Technical and Quality Requirements override all other standards. The delivery destination is USS GRIDLEY DDG 101, FPO AP 96666, with shipping instructions tied to DLA Procurement Note C19 and RDD 777. The contract includes a zero variance tolerance on quantity, inspection and acceptance occur at destination, and the product is subject to FDA regulation. The solicitation requires buyers to submit referrals via EBS to confirm bidder and manufacturer details, and the contract is governed by DLA’s technical and quality requirements effective at the time of award, with all markings and packaging strictly aligned to current DLA medical marking standards.

General Info

10 bottles of 400 mg moxifloxacin tablets, 36-month shelf life, shipped to USS GRIDLEY per DLA medical standards.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100206 BOX 1, FPO, AP, 96666, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4348.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
NICHOLAS QUIGLEY
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
MOXIFLOXACIN HYDROCHLORIDE TABLETS
MOXIFLOXACIN HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
400 MG 30'S TABLETS PER BOTTLE. UNIT OF ISSUE "BOTTLE". STORE AT
CONTROLLED ROOM TEMPERATURE; AVOID HIGH HUMIDITY .. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 30 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4348
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-7387-56 RISING PHARMA HOLDINGS, INC. 8FG82 P/N NDC57237-0156-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017651238 0001 BT 10.000
NSN/MATERIAL:6505015034772
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R23151
USS GRIDLEY DDG 101
UNIT 100206 BOX 1
FPO AP 96666
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
SPE2DP-26-T-4348
SECTION B
PR: 7017651238 PRLI: 0001 CONT’D
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R23151
USS GRIDLEY DDG 101
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R231516206HM87
RDD: 777
PROJ: EP5 TP 2
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/30/2026
SPE2DP-26-T-4348 NSN/Part Number: 6505-01-503-4772 Quantity: 10 BT Purchase Request: 7017651238QTY: 10 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
FLUORESCEIN SODIUM OPHFluorescein Sodium Ophthalmic Strips, USP, are procured as a single unit of 100 individually sealed strips at 1 mg each, packaged in commercial unit containers designed to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to the designated point of supply. All packaging and marking must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must include the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, and contract or lot number. The product has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, with exceptions limited to specific functional uses in batteries, lighting, instruments, sensors, controls, weapon systems, or NAVSEA-approved chemical reagents; portable fluorescent lamps or instruments containing mercury must be shockproof and include a secondary containment barrier per NAVSEA 5100-003D. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard (HCS) compliant labels in accordance with 29 C.F.R. 1910.1200, replacing MSDS requirements effective June 1, 2015, and ensure employee training on all updated labeling and documentation standards. The item is regulated by the FDA, and buyers must submit referrals to confirm compliance. Delivery is FOB destination within 20 days with no variance allowed in quantity, and the product must adhere to MIL-STD-2073-1E packaging standards. The contract reference is SPE2DP-26-T-4346, with a response deadline of August 3, 2026, and the point of contact is James McCullough at DLA Troop Support.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTThe contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, packaged in 1-ounce collapsible tubes weighing 28.35 grams each, with the unit of issue being the tube. The product must comply with FDA regulations and meet stringent technical and quality standards as defined by the DLA Master List of Technical and Quality Requirements, including proper labeling per MEDICAL MARKING STANDARD NO. 1 and packaging consistent with MIL-STD-129 and RP001. The ointment has a non-extendable shelf life of 36 months and must be stored at controlled room temperature not exceeding 30°C (86°F). The item is identified by NSN 6505-00-150-1990 and manufacturer part number NDC67777-0223-11 supplied by DYNAREX CORP. Two delivery line items are specified: 10 tubes for delivery to Richmond, Virginia, and 4 tubes for delivery to Melrose, Massachusetts. Both shipments are required within five days of contract award, delivered FOB destination with zero quantity variance, inspected and accepted at the destination. Packaging must adhere to ASTM D3951 if non-hazardous, but DLA requirements supersede all others. Shipping must occur via traceable methods, excluding parcel post, and all markings must follow government specifications. The original required delivery dates are July 29 and July 30, 2026, with the contract solicitation number SPE2DP-26-T-4335 and point of contact James McCullough.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ZOLMITRIPTAN TABLETZolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
INSECT REPELLENT SPThe contract is for a 100% biodegradable insect repellent spray with a non-DEET formula and citrus scent, packaged in 2-ounce units, with a total quantity of 30 units required. The item is identified by NSN 6505-01-512-8504 and is part of a solicitation issued under SPE2DP-26-T-4349 with a response deadline of August 3, 2026. The product must comply with technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, with applicable revisions determined by the solicitation or award date. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and copies of the standard are obtainable through DLA Troop Support or online. A current Material Safety Data Sheet (MSDS) is mandatory and must be submitted electronically to DLA.MSDS@DLA.MIL using the required cover sheet (P-75), with a physical copy included in every shipment. The repellent is classified as a hazardous material, requiring packaging that meets 49 CFR and ICAO regulations. Delivery is due within 20 days of award to Fort Campbell, Kentucky, and point of contact is Vanesa M Carbo Acevedo, with additional logistics and compliance oversight by the Department of Defense’s Medical Supply Chain Pharma FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTIONThe contract specifies the procurement of 2 bottles of Emollient Lotion, each containing 240 mL (8 FL OZ), packaged in a non-sterile bottle with a dispenser cap. The lotion must be an oil-in-water or water-in-oil emulsion containing a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional compliant ingredients such as stabilizers, thickening agents, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. It must maintain a pH between 5.0 and 8.1 and exhibit a viscosity of 10,000 to 20,000 CPS at 25°C when measured with a Brookfield Viscometer Model LVT using Spindle No. 13 at 6 RPM. The product is regulated by the FDA and must be stored at controlled room temperature. Packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 unless superseded by stricter DLA requirements. The unit of issue is a bottle (BT), and delivery is required FOB destination within 20 days of contract award to a military installation at Fort Bliss, Texas. No quantity variance is permitted, and inspection and acceptance occur at the destination. Traceable shipping methods are mandatory, and parcel post is prohibited. The contract reference number is SPE2DP-26-T-4329, with a required delivery date of July 29, 2026, and the product is identified by NSN 6508-01-019-7181. The supplier must meet all technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTIONDextrose Injection 5% USP is a sterile, nonpyrogenic intravenous solution supplied in 1000 mL single-dose plastic bags, with each bag containing 50 grams of anhydrous dextrose USP dissolved in water for injection USP. The product is latex-free and intended solely for intravenous administration, packaged in units of 12 bags per package. It is classified as a Type I (Code P) item with a non-extendable shelf life of 30 months and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat. The item is subject to the latest Medical Marking Standard No. 1 for labeling and packaging, and defense information may apply under RD003. Packaging and delivery must comply with MIL-STD-2073-1E. The solicitation SPE2DP-26-T-4336 calls for two packages (24 bags total) to be delivered within five days FOB destination, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point, and the contract is managed by the Department of Defense under the Medical Supply Chain PHARM FSA. The item is identified by NSN 6505-01-330-6252 and is procured under a fixed unit price; only suppliers meeting the DLA Master List of Technical and Quality Requirements referenced in RA001 are eligible. The contract is part of a federal procurement with NAICS code 325412, and the primary point of contact is James Foggie at DLA. Manufacturers listed include ICU Medical, Inc. and B. Braun Medical Inc., each with approved NDCs.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ANESTHESIA SET, EPIDURAThe ANESTHESIA SET, EPIDURAL is a specialized medical device comprising a 20 GA catheter and a 17 GA TUOHY SCHLIFF WINGED NEEDLE, contained in a single package with 29 total components. Each package contains ten units and is the standard unit of issue, with the entire lot required to have a shelf life of 12 months and no more than two months having passed from the date of manufacture to the date of delivery to the government. The product is identified by NSN 6515-01-323-6531 and is subject to strict technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements, with compliance determined by the revision in effect on the solicitation or award date depending on acquisition size. Packaging must adhere to DLA requirements, and any non-accepted supplies must have government identification removed prior to return. Bidders are required to clearly specify the source and part number being supplied. This solicitation, issued under contract SPE2DS-26-T-281G with a response deadline of August 3, 2026, is managed by the Department of Defense’s Medical Supply Chain and requires delivery to APO 09094-3219 within 20 days of award.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SODIUM PERBORATESodium peroxide in powder form, packaged in 100-gram bottles, is being procured under solicitation SPE2DP-26-T-4343 with a strict requirement of one unit of issue per bottle and a delivery deadline of five days after award. The item has a non-extendable shelf life of 36 months and must be stored away from high humidity and temperatures exceeding 32 degrees Celsius, as well as kept separate from flammable materials due to its chemical nature. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere to DLA packaging requirements, with hazardous material handling governed by TQ requirement IP025 if classified under FED-STD-313, otherwise meeting ASTM D3951 commercial packaging standards, though DLA’s technical and quality requirements take precedence. The item is regulated by the FDA, requiring a referral through EBS to confirm specifications, and must be shipped via traceable freight methods—parcel post is prohibited. Delivery is FOB destination to PCU JOHN F KENNEDY CVN-79 in Suffolk, Virginia, with no variance allowed in quantity. The contract references the DLA Master List of Technical and Quality Requirements for compliance, and the supplier must clearly identify the source and part number, with approved vendors including Sultan Chemists Inc., Henry Schein Inc., and Patterson Dental Supply, Inc. The required delivery date is July 30, 2026, and the solicitation response deadline is August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BUPIVACAINE HYDROCHBupivacaine Hydrochloride Injection USP 0.5% in 50 mL vials is being procured under contract SPE2DP-26-T-4347 for delivery to a U.S. military facility in Kwangju, South Korea, with a required delivery date of July 30, 2026. The item is manufactured by Pfizer Inc under NDC 00409-1163-18 and must comply with FDA regulations, requiring pre-award confirmation through EBS referral. The product has a non-extendable 24-month shelf life and must be stored at controlled room temperature between 20°C to 25°C. Packaging and marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed in commercial containers capable of protecting against damage and suitable for low-cost Carrier shipment. Palletization and packaging must meet DLA’s RP001 requirements, and hazardous material shipping protocols under IP025 apply. The contract specifies a fixed quantity of three vials with zero variance allowance, and inspection and acceptance occur at destination. The delivery is FOB destination, with a 20-day lead time and a requirement for government-compliant labeling and documentation. All technical, quality, and packaging specifications are governed by the DLA Master List of Technical and Quality Requirements referenced in RA001, with compliance enforced as of the solicitation issue date.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
CHLORINE TEST REAGEThe contract specifies the procurement of Chlorine Test Reagent, a DPD total chlorine reagent packaged in 100 powder pillows, each designed for a 10 mL sample size, with the unit of issue being one package containing 100 units. The item is identified by NSN 6550-01-460-7597 and requires a shelf life of 60 months, non-extendable, with no more than eight months elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all labels must clearly indicate the date of manufacture, expiration or retest date, and the contract or lot number, in accordance with the latest revision of MMS1C. The reagent must be shipped in sealed, commercial-grade containers capable of protecting against damage and must be packed in exterior shipping containers suitable for safe delivery at the lowest possible rate to the specified point of delivery, FPO ZIP 09578. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and applicable defense information controls are in effect. Supply packaging adheres to DLA packaging standards, and government identification must be removed from non-accepted supplies. The solicitation number is SPE2DS-26-T-79S, issued on July 28, 2026, with a response deadline of August 3, 2026, under a federal procurement managed by the Department of Defense’s Medical Supply Chain MD Surg FSF office, and delivery is required within 20 days after award.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPovidone-Iodine Cleansing Solution, USP, with 7.5% active ingredient, is supplied for external use only in one-gallon bottles identified by the unit of issue BT, with a total shelf life of 36 months requiring at least 31 months to remain upon delivery to the first government activity. The product must be stored at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F–86°F). Compliance with the DLA Master List of Technical and Quality Requirements is mandatory, superseding ASTM D3951, and packaging must adhere to DLA Packaging Requirements for Procurement and the Medical Marking Standard No. 1, replacing MIL-STD-129. The item is regulated by the FDA and classified as hazardous under Fed-Std-313, necessitating Safety Data Sheets and Hazard Communication Standard labels in full compliance with 29 C.F.R. 1910.1200, along with employee培训 on GHS-aligned labeling and SDS protocols. The solution is supplied by Cardinal Health 200, LLC and Purdue Pharma LP under NDC 67618-0151-01 and must be shipped via traceable means only, prohibiting parcel post, with delivery to multiple U.S. Navy vessels and support units across FPO addresses. Each of the six order lines specifies a firm fixed price with zero tolerance for quantity variance, inspection and acceptance occurring at destination, and delivery required within 30 days after award. All shipments must follow DLA-specific transportation and palletization directives and include government-unique identifiers and routing details.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATIONThe contract is for a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and labeled as sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue is a package containing 24 tubes of 3 ounces, with a total shelf life of 24 months and a minimum of 21 months remaining at time of delivery to the first government activity. Storage must be maintained between 15°C and 30°C (59°F and 86°F) in a cool, dry environment. The product is regulated by the FDA and must comply with all DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be sealed and shipped in commercially appropriate containers that ensure safe delivery via common carrier at the lowest cost to the specified delivery points. Palletization must follow DLA packaging requirements, and shipment must occur by the fastest traceable means, excluding parcel post. The material is not classified as hazardous under FED-STD-313, so commercial packaging per ASTM D3951 applies unless overridden by stricter DLA requirements. Three separate delivery line items exist, totaling four pallets, with delivery addresses at military installations in Massachusetts, North Carolina, and aboard the USS Gridley via FPO. All deliveries are FOB destination with zero quantity variance, inspected and accepted at the delivery point, with required delivery dates ranging from July 29 to July 30, 2026. The solicitation number is SPE2DP-26-T-4340, with a response deadline of August 3, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
PHENYLEPHRINE HYDROThe contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.
Medicinal and Botanical Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.
Medicinal and Botanical Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 423450
New
DIBBS
ATROPINE SULFATE INAtropine Sulfate Injection, USP, is a sterile, nonpyrogenic, preservative-free, and non-DEHP product supplied in a 5 mL single-dose syringe with a 20-gauge by 1.5-inch protected needle featuring a male Luer lock adapter. Each milliliter contains 0.1 mg of atropine sulfate monohydrate and 9 mg of sodium chloride, resulting in a total of 0.5 mg of atropine per syringe. The medication is indicated for subcutaneous, intramuscular, or intravenous administration and is labeled RX only. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and has a non-extendable shelf life of 24 months. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all DLA Master List of Technical and Quality Requirements take precedence over commercial packaging standards. The product is regulated by the FDA and is supplied by Pfizer Inc with NDC code 00409-4910-34. The contract, issued under solicitation number SPE2DP-26-T-4325, requires delivery of one pallet (PG) containing ten units to Fort Bragg, North Carolina, within 20 days of order placement, FOB destination. No quantity variance is permitted, and inspection and acceptance occur at the delivery point. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, unless overridden by DLA requirements. All packaging must be marked and labeled per DLA specifications, palletized as per RP001, and shipped via traceable means, excluding parcel post. The delivery is mandated for July 29, 2026, with the contract awarded to the Department of Defense, Medical Supply Chain Pharm FSA, and all technical, quality, and packaging specifications are governed by the DLA Master List in effect on the solicitation issue date. A referral must be sent via EBS to confirm bidder and manufacturer details prior to award.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
DIETARY SUPPLEMENT, THEThe product is an unflavored therapeutic dietary supplement in powder form, packaged in 80-gram units, with each packet reconstituted to yield 8 to 10 ounces of liquid. It is lactose-free and supplied in packages containing six individual units, with a unit of issue defined as a package. Each package must have an 18-month shelf life from the date of manufacture, and no more than three months may elapse between the manufacture date and delivery to the government. Packaging must comply with commercial standards as specified, using sealed unit containers to protect contents from damage, and exterior shipping containers must ensure safe, cost-effective delivery via common carriers. Labeling and marking must follow Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA Packaging Requirements for Procurement. All technical and quality requirements from the DLA Master List take precedence over ASTM D3951. The item is subject to firm fixed pricing with zero variance in quantity, inspection and acceptance occur at destination, and delivery is due within 35 days after order date. Shipping must be via traceable freight methods only, not parcel post, with specified delivery addresses for two distinct locations. The contract includes clauses related to veteran employment reporting, sustainable product procurement, and Wide Area Workflow payment processing. The National Stock Number is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.
Medicinal and Botanical Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 423450
New
DIBBS
LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. Each unit of issue consists of a package of 50 cartridges, organized in five blisters of ten per cardboard box. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and has a non-extendable shelf life of 18 months as a Type I (Code K) item. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is sealed, protected from damage, and shipped in suitable commercial containers to guarantee safe delivery. Technical and quality requirements referenced in the document are governed by the DLA Master List of Technical and Quality Requirements, with revisions controlled based on solicitation or award date depending on acquisition type. This procurement is issued under Solicitation Number SPE2DP-26-T-4333 by the Department of Defense’s Medical Supply Chain Pharm FSA. One pack (PG) of 50 cartridges is required, with a delivery requirement of five days after award, delivered FOB destination to JBER, Alaska. The NSN is 6505-01-576-2767 and the purchase request number is 7017631646. The product must be supplied by an approved manufacturer with part number NDC66312-0181-16 or equivalent, and shipment must adhere to all DLA packaging standards, including commercial packaging for medical items and specific marking requirements. No quantity variance is permitted, and inspection and acceptance occur at the destination. The required delivery date is July 29, 2026, and the response deadline for the solicitation is August 3, 2026. The contracting officer must submit a referral in EBS for confirmation, including manufacturer and bidder details. Transportation and delivery logistics are governed by DLA procedural notes C19 and C20, with the point of contact for inquiries being Timothy McCauley.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details